Price T Rowe Associates Inc Caribou Biosciences, Inc. Put Options Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CRBU
# of Institutions
145Shares Held
53.7MCall Options Held
32.5KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$12.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$8.32 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.16MShares$7.62 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.08MShares$7.47 Million0.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.62MShares$4.8 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $111M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...